Check out our most popular compounded medications! Get Started
The Estriol 1 mg/Estradiol 0.25 mg Oral Troches are square-shaped solid dosage forms intended for buccal administration. These troches are formulated to dissolve slowly in the mouth, allowing for the absorption of medication through the oral mucosa. This delivery method is designed to provide either targeted local relief or systemic effects, depending on the clinical indication. The combination of estriol and estradiol in these troches is commonly used in hormone replacement therapy for the management of menopausal symptoms such as hot flashes, vaginal atrophy, and osteoporosis. Additionally, this formulation may be employed in the treatment of hormone-responsive conditions such as certain menopause-related mood swings and prevention of bone loss.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Estriol 1 mg/Estradiol 0.25 mg Oral Troches are square-shaped solid dosage forms meticulously crafted to dissolve gradually in the mouth. This unique delivery system is designed to facilitate the absorption of medication through the oral mucosa, which can lead to targeted local effects or systemic distribution, depending on the intended therapeutic outcome. The combination of estriol and estradiol in these troches harnesses the benefits of both estrogenic compounds, offering a dual approach to hormone replacement therapy (HRT).
The lower concentration of estradiol in this formulation is balanced by the presence of estriol, aiming to minimize potential side effects associated with estrogen therapy. This balance is particularly beneficial for patients who may be sensitive to higher doses of estradiol or those who are looking for a gentler introduction to HRT.
The oral troche form is advantageous for patients who may have difficulties swallowing pills or prefer a more convenient and discreet method of administration. The slow dissolution of the troche ensures a sustained release of the hormones, providing a steady absorption rate and potentially reducing the incidence of peaks and troughs in hormone levels. This can lead to a more consistent therapeutic effect and improved patient compliance.
Estrogen therapy has been associated with an increased risk of certain conditions, such as thromboembolic events, stroke, and breast cancer. Therefore, it is crucial to evaluate the risks and benefits on an individual basis and to use the lowest effective dose for the shortest duration necessary. Regular monitoring and follow-up with a healthcare provider are essential to ensure the safe use of this medication.
For those considering Estriol 1 mg/Estradiol 0.25 mg Oral Troches, or for healthcare professionals interested in prescribing this formulation, please note that it is a compounded medication. As such, it is prepared specifically for individual patients based on a prescriber's order, allowing for customization to meet specific patient needs. If you have any questions or require further information about this formulation and its suitability for treating menopausal symptoms or other hormone-related conditions, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to provide guidance and support.
Estriol and estradiol are forms of estrogen, a female hormone involved in various physiological processes. When compounded into a troche, they are intended to be absorbed through the oral mucosa, which can provide a more direct route into the bloodstream and potentially reduce first-pass metabolism by the liver. This formulation is often used in hormone replacement therapy for menopausal symptoms, such as hot flashes, vaginal dryness, and osteoporosis prevention. It may also be used in certain cases of estrogen deficiency or as part of transgender hormone therapy.
When considering the use of estriol and estradiol troches, it is important to be aware of potential drug interactions. Estrogens can interact with a variety of medications, potentially altering their effects. For example, they can reduce the effectiveness of aromatase inhibitors (e.g., anastrozole, letrozole) used in breast cancer treatment. Concurrent use with thyroid hormone replacement therapy may necessitate adjustments in the thyroid medication dose, as estrogens can increase thyroid-binding globulin levels, affecting thyroid hormone availability.
Estrogens may also interact with anticoagulants such as warfarin, requiring close monitoring of coagulation parameters and possible dose adjustments of the anticoagulant. They can also affect the metabolism of certain benzodiazepines, cyclosporine, and tricyclic antidepressants, potentially leading to increased effects or toxicity of these drugs. Additionally, some anticonvulsants (e.g., phenobarbital, phenytoin, carbamazepine) and certain antibiotics (e.g., rifampicin) can increase the metabolism of estrogens, reducing their effectiveness.
Grapefruit juice can increase the levels of estradiol by inhibiting its metabolism, which may lead to enhanced or prolonged effects. Patients should be advised to avoid grapefruit and grapefruit juice while taking this medication. Smoking tobacco can also reduce the effectiveness of estrogens and increase the risk of certain side effects, such as thrombosis. Therefore, patients are generally advised to quit smoking if they are taking estrogen-containing medications.
It is crucial for patients to inform their healthcare providers of all medications, supplements, and herbal products they are currently taking to avoid potential interactions. Healthcare providers should review the patient's medication profile for interactions before prescribing estriol and estradiol troches and monitor the patient for any signs of adverse effects or changes in the efficacy of their other medications. If you have any questions or require further information regarding this formulation and its interactions, please reach out to us at Bayview Pharmacy for assistance.
Estriol 1 mg/Estradiol 0.25 mg Oral Troches are square-shaped solid dosage forms that are specifically designed to dissolve slowly when placed in the mouth. This unique delivery system allows the active ingredients, estriol and estradiol, which are naturally occurring estrogens, to be absorbed directly through the oral mucosa. The advantage of this route of administration is that it bypasses the gastrointestinal tract and first-pass metabolism in the liver, potentially reducing systemic side effects and improving the bioavailability of the hormones.
The combination of estriol and estradiol in these troches is used to address symptoms associated with estrogen deficiency, such as those experienced during menopause. Estriol is considered a weaker estrogen and is often used for its beneficial effects on the urogenital tract, helping to alleviate symptoms like vaginal dryness and atrophy. Estradiol, on the other hand, is a more potent form of estrogen and can help in relieving a broader range of menopausal symptoms, including hot flashes, night sweats, and osteoporosis. By combining these two estrogens, the troches aim to provide a balanced approach to hormone replacement therapy (HRT), targeting specific symptoms with the potential for fewer side effects.
The troches are typically used in patients who require HRT and may be particularly beneficial for those who have difficulties with other forms of administration, such as oral tablets or transdermal patches. The direct absorption through the oral mucosa also allows for a more consistent delivery of the hormones, which can be important in managing the symptoms effectively. It is important to note that hormone therapy should be tailored to the individual needs of the patient, and the use of estriol and estradiol troches should be based on a thorough evaluation by a healthcare provider.
For patients and prescribers considering this formulation, it is crucial to understand that hormone replacement therapy with estriol and estradiol should be used with caution, especially in individuals with a history of hormone-sensitive cancers, thromboembolic disorders, or liver disease. Regular monitoring and follow-up with the healthcare provider are essential to ensure the safety and efficacy of the treatment. If you have any questions or require further information about Estriol 1 mg/Estradiol 0.25 mg Oral Troches, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the support and guidance you need for successful treatment outcomes.
Estriol 1 mg/Estradiol 0.25 mg Oral Troches are compounded medications combining two forms of estrogen hormones. These square-shaped solid dosage forms are designed to dissolve slowly in the mouth, allowing for absorption through the oral mucosa for either local or systemic effects.
To use the oral troches, place one in your mouth and allow it to dissolve slowly without chewing or swallowing it whole. This allows for the medication to be absorbed directly through the tissues in your mouth.
Your healthcare provider will determine the proper dosage and frequency for your particular condition. It is important to follow their instructions precisely. Do not alter the dosage without consulting your provider.
By dissolving directly in the mouth, the hormones in the troches bypass the digestive system and liver initially, which may reduce the risk of certain side effects and potentially improve efficacy. This form can be advantageous for targeted treatments and for individuals who have difficulties swallowing pills.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and resume your normal dosing schedule. Do not double doses without consulting your healthcare provider.
It is best to avoid eating or drinking anything until the troche has completely dissolved to ensure full absorption. Follow your healthcare provider's instructions regarding how long to wait before eating or drinking.
As with any medication, side effects are possible. Some common side effects may include nausea, headaches, breast tenderness, and mood swings. If you experience any severe side effects or if common side effects persist, contact your healthcare provider immediately.
These medications are generally not recommended for use during pregnancy or while breastfeeding. You should discuss all potential risks with your healthcare provider before starting any new medication if you are pregnant, planning to become pregnant, or breastfeeding.
Store the troches at room temperature away from moisture and heat. Keep them in their original packaging until ready to use, and keep them out of reach of children and pets.
While these hormones are primarily prescribed for women, there may be circumstances where a healthcare provider prescribes them for a man. Always follow the guidance from your healthcare provider regarding treatment and proper use.
There are no specific dietary requirements associated with the use of Estriol/Estradiol Troches, but maintaining a balanced diet can support overall health. Your healthcare provider may provide additional instructions if necessary for your condition or if you take other medications that could be affected by diet.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
